Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$344K Sell
9,099
-48
-0.5% -$1.96K 0.3% 55
2023
Q2
$373K Sell
9,147
-355
-4% -$14.7K 0.3% 52
2023
Q1
$398K Buy
9,502
+183
+2% +$7.63K 0.3% 43
2022
Q4
$403K Buy
9,319
+393
+4% +$15.5K 0.34% 43
2022
Q3
$334K Buy
8,926
+600
+7% +$26.5K 0.29% 52
2022
Q2
$377K Sell
8,326
-58
-0.7% -$2.73K 0.32% 42
2022
Q1
$399K Sell
8,384
-5,975
-42% -$253K 0.34% 44
2021
Q4
$592K Buy
+14,359
New +$541K 0.44% 15

Other funds holding EXC

Syntax Advisors's EXC Position: Q3 2023 in Review

Syntax Advisors reduced its Exelon (EXC) stake by 0.52% in Q3 2023, selling an estimated $1.96K and leaving 9,099 shares worth $344K. The position accounts for 0.3% of the portfolio, ranked #55.

Syntax Advisors first reported a position in EXC in Q4 2021 and has held it in 8 quarters since. The position peaked at $592K in Q4 2021. 997 funds tracked by Wall St. Rank hold EXC as of Q3 2023.

  • Syntax Advisors held 9,099 shares of Exelon worth $344K as of Q3 2023.
  • Syntax Advisors sold 48 Exelon shares in Q3 2023, an estimated $1.96K.
  • Exelon made up 0.3% of Syntax Advisors's portfolio in Q3 2023, its #55 holding.
  • Syntax Advisors first reported a position in Exelon in Q4 2021 and has held it in 8 quarters since.
  • Syntax Advisors's Exelon position peaked at $592K in Q4 2021.
  • 997 funds tracked by Wall St. Rank held Exelon as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.